Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02508655
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ALY | N(6)-ACETYLLYSINE | A,B | 2B4D | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD9 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVR | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVS | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVQ | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OT7 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B5G | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2GIV | 0.71 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNY | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 1JSP | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,I,L | 2V5W | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,D | 3D4B | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OQ6 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R0Y | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 3CZ7 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 1JM4 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H4H | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2J6V | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R10 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1YC5 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OX0 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2G | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,D | 2H4F | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2OU2 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1S5P | 0.71 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNW | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 3D35 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD2 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2ZFN | 0.71 | |
ALY | N(6)-ACETYLLYSINE | C,D | 2C1J | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQG | 0.71 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNX | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1MA3 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2H | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2I2Z | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD7 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | P | 1E6I | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZC | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D,I,J, K,L | 3EWF | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2D | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1Q1A | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZD | 0.71 | |
ALY | N(6)-ACETYLLYSINE | Q,R | 2E3K | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2OZU | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQF | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C | 2R0V | 0.71 | |
INC | 2-(ACETYL-HYDROXY-AMINO)-4-METHYL- PENTANOIC ACID METHYL ESTER | A | 7TLN | 0.7 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.73 | |
HTF | N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE | A | 2AVX | 0.7 | |
BCV | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- D-CYCLOPROPYLGLYCINE | A | 2IVJ | 0.71 | |
169 | 1-(4-TERT-BUTYLCARBAMOYL-PIPERAZINE- 1-CARBONYL)-3-(3-GUANIDINO-PROPYL)- 4-OXO-AZETIDINE-2-CARBOXYLIC ACID | A | 1RXP | 0.71 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.74 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.74 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.75 | |
CIB | 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1- (1-FORMYL-PENTYLCARBAMOYL)-3-METHYL- BUTYL]-AMIDE | H,I,J,K,L,M,N | 1J2Q | 0.75 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.72 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.73 | |
ABX | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 4-(METHOXYCARBONYL)PROLINE | A | 1XOE | 0.71 | |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.75 | |
L2A | (2S,5S,8S,11S,15E,20S)-20-amino- 2-(carboxymethyl)-11,20-dimethyl- 5,8-bis(2-methylpropyl)-3,6,9,21- tetraoxo-1,4,7,10-tetraazacyclohenicos- 15-ene-11-carboxylic acid | B | 2K1C | 0.71 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3EDZ | 0.72 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3EWJ | 0.72 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 2DDF | 0.72 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B,C,D | 2I47 | 0.72 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,C,E,I | 1BKC | 0.72 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 2FV9 | 0.72 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3E8R | 0.72 | |
0AG | N-(ethoxycarbonyl)-L-leucine | I,J | 1PSA | 0.71 | |
ACW | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- B-METHYL-D-CYCLOPROPYLGLYCINE | B | 2IVI | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.73 | |
AMK | (S)-4-AMINO-4-{(S)-1-[(S)-2-CARBAMOYL- 1-((S)-1-{(S)-[(1R,2R)-2-((S)-1- CARBOXY-ETHYLCARBAMOYL)-CYCLOPENTYL]- HYDROXY-METHYL}-3-METHYL-BUTYLCARBAMOYL)- ETHYLCARBAMOYL]-2-METHYL-PROPYLCARBAMOYL}- BUTYRIC ACID | A,B,C | 1YM4 | 0.71 |